introduction
Medical texts on cancer etiology discuss increasingly heritable causes and related genetic mechanisms, 'X% of the patients with cancer Y report a family history' [1, 2] . Such data are indeed relevant because family history and twin concordance are the only population-level pieces of evidence informative of a possible heritable etiology, with an important caveat that environmental causes of cancer may also cause familial aggregation [2, 3] . Known cancer syndromes with identified gene defects explain only a small proportion of the known familial aggregation of any common cancers [4] [5] [6] [7] [8] . Whenever family history is discussed, it needs to be specified as to the number of generations covered (first degree, second degree, etc.) and to the ages of at least the youngest generation. Both these variables have a drastic impact on the implications of a family history. Nevertheless, an unqualified reference to a family history is commonplace. In expert reviews on specific cancers, unreferenced statements are made 'X% of the patients have a family history of the cancer', and this figure is then cited as a proof of heritable etiology in numerous subsequent publications by other authors. The multiauthor treatise, The Genetic Basis of Human Cancer carries 18 chapters on sitespecific cancers, of which nine make a reference to a family history, but only two specify what is meant [9] . Furthermore, in most literature on familial cancer, patients have been asked about cancers in their relatives without confirming the reports. The accuracy of reporting a family history depends on many factors, including the type of cancers; the reporting is notoriously inaccurate for many internal cancers [10, 11] .
An unambiguous definition of the proportion of cases with an affected relative (familial proportion) is possible through a nationwide familial dataset, such as the Swedish FamilyCancer Database, with registered families and medically verified cancers from the Swedish Cancer Registry [12, 13] . Using this resource, we define the proportion of concordant (same) familial cancers for all cancers in a population that has reached age 72 years. We divide the families into three distinct types through the relationship of the affected individuals: parentoffspring pairs, two or more siblings or parent and two or more siblings. These distinct types have implications to the causes of familial aggregation. Common cancers occur in families more frequently than rare cancers but we demonstrate that the prevalence does not alone explain the familial aggregation.
subjects and methods
The Family-Cancer Database has been created by linking information from the Multi-Generation Register, national censuses, Swedish Cancer Registry original article and death notifications [12, 13] [13] .
Calculations were based on individuals with identified parents (7.45 million offspring aged 72 years or below), who were followed from birth, immigration date or 1961, whichever came latest, until diagnosis of any cancer, death, emigration or 31 December 2004, whichever came first (median length of follow-up 33 years). Individuals affected by cancer during the follow-up period were further classified according to a family history of cancer at the concordant site. Three different types of family history were considered: individuals with an affected parent (parent as proband) and with no affected sibling, individuals with at least one affected sibling and without an affected parent and individuals with one affected parent and at least one affected sibling. The cumulative risk of site-specific cancer before age 73 years was also estimated for the general offspring population and for individuals with at least one affected sibling. Cumulative rates were calculated as the sum of age-specific incidence rates multiplied by the width of the age groups (<20, 20-24, 25-29, ., 65-69 and 70-72 years). Then, the cumulative risk was computed as 100 · (1 2 e cumulative rate/100 ), where e is the base of the natural logarithm [14] .
results
We analyzed the proportion of concordant familial cancers in a 72-year-old population of offspring whose parents' ages were not limited, covering 34 cancer sites (and additionally colorectum) and 205 638 cases (Table 1) . Prostate cancer showed the highest familial proportion of 20.15%, followed by breast (13.58%) and colorectal (12.80%) cancers. Salivary gland cancers showed the lowest familial proportion of 0.15%, but bone, laryngeal, anal, connective tissue and other genital cancers also remained <1%.
The most common familial clusters were the affected parentoffspring pairs which accounted for 68.7% of all familial cases, for example, 2478/3587 = 69.1% for prostate, 63.5% for breast and 80.1% for colorectal cancers (Table 1) . Affected siblings in families where parents were not diagnosed with a concordant cancer accounted for 23.9% for prostate, 32.1% for breast and 15.9% for colorectal cancers. Small intestinal, testicular and bone tumors and Hodgkin's disease were notable exceptions as for these cancers affected siblings were more numerous that affected offspring of affected parents. Families with affected parents and multiple affected offspring were rare, accounting for 4.5% of all familial cases and for some sites no such families were found; thyroid (18.1%) and small intestinal (14.3%; however only one family) tumors were exceptions with high proportions. Families with multiple affected members were also common for prostate cancer (7.0%), while for breast cancer (4.4%) the percentage was close to the average. Figure 1 shows the dependence of the cumulative risk of cancer in siblings of affected individuals on the cumulative risk of that cancer in the whole population. The results include cancers for which at least 10 affected siblings were recorded. The diagonal line in the log-log scale shows the expected cumulative risks for siblings of affected individuals if these individuals were at the same risk as anyone in the population; this risk increases linearly as a function of the population prevalence of the particular cancer. All observed cumulative risks lay above the diagonal, with a distance to the diagonal proportionate to the familial risk of cancer for this site.
discussion
The present familial proportions show the prevalence of familial cancers in a 72-year-old Swedish population. About 85% (13 707 of 16 075) of the familial cancers in this population were diagnosed from years 1990 to 2004. The Swedish incidence patterns of cancer are similar to the Northern and Western European and North American white populations [15] . During the 1990s, large increases in incidence have taken place for breast cancer because of the implementation of the nationwide mammography screening program [16] [17] [18] [19] and for prostate cancer because of opportunistic prostate-specific antigen screening [20] . Cervical cancer screening was implemented in Sweden in the 1960s, while for colorectal cancer no national programs have been launched. Practically, all cancers in the Swedish Cancer Registry are histologically verified and thus diagnostic accuracy is uncompromised [21] . We have noted earlier that family members may be diagnosed close in time for some screeningdetected cancers, but such lead-time bias has hardly any effect on the overall familial risks [22] .
The familial proportion depends on the age-specific prevalence of the particular cancer and its familial risk. The familial proportions were calculated for mutually exclusive family types of affected parent-offspring and sibling pairs and of affected parents and multiple siblings. Thus, the familial proportion is strictly defined within two generations of firstdegree relatives. The proportions were high for the common cancers of the prostate (20.15%), breast (13.58%) and colorectum (12.80%). They exceeded 5% even for lung, stomach and urinary bladder cancers. These percentages can justifiably be used in statements 'X% of the patients have a family history of the cancer', as long as the population age and family structures are explained. When the population ages, the cumulative risks of cancer increase. However, as an opposite trend, familial risks tend to be lower for older individuals [23] , and thus the net effect of aging on the familial proportion depends on the balance between these two trends, which will be specific to the cancer type. A word of caution is in order about the comparability of the data between cancers sites. The offspring generation was truncated at age 72 years, which is barely over the median diagnostic age of cancer in the Swedish Cancer Registry (70 years). Thus, the present study scores larger proportions of early onset than late onset familial cancers.
Many publications give familial risks (for which familial proportion needs to be calculated but which often remain unreported) for 'first-degree relatives', whom clinicians never see. Here, we define familial proportions to a specific family relationship to correspond the clinical situation. Moreover, the defined family relationship may have mechanistic implications: original article Annals of Oncology parent-offspring concordance, particularly when several offspring are affected, may arise through dominant heritable effects while sibling concordance may be due to recessive effects, when parents remain unaffected [24] . Environmental factors may cause similar aggregation and siblings may be affected if exposures, e.g. infections, take place during childhood. Familial proportions may even witness therapeutic improvements in early onset cancers: survival for Hodgkin's disease and testicular cancer has drastically improved in the 1980s with affected siblings surviving but affected parents dying before the end of their reproductive period. The familial proportion would then be relatively higher for siblings than for parent-offspring pairs.
How generalizable are the present results? Limited data are available on familial proportions from outside Sweden. The proportions can be calculated from the year 1994 publication on The Utah Population Database, with the distinction that this source counted familial cancers for all first-degree relatives of cases, e.g. considering three generations, instead of the present two generations, although probably the young offspring generation contributed a few familial cancers [25] . The results on familial proportions were curiously similar to the present ones, for example, for prostate 21.7% (present 20.15%), breast 14.0% (13.58%) and colorectal 10.8% (12.80%) cancers. The agreement in these common cancers is excellent even though the covered periods were different, yet overlapping. For less common cancer sites the agreement was not as good, but the present number of familial cases, about five times larger than that in the Utah study, should guarantee precision even down to rare familial cancers. A more indirect way of examining the generalizability of the result would be to 
